2026 NPPES data Pulmonary Disease Physician NPI 1669449591 M.D.
Verify on CMS →

AHMAREEN KHAN, M.D.

Pulmonary Disease Physician in SAINT CHARLES, Missouri. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
4K
Medicare Part D claims · 509 beneficiaries · Pulmonary Disease Physician avg: 1K
Generic prescribing
35%
generic claims · 65% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

AHMAREEN KHAN, M.D. filed 3,529 Medicare Part D claims in 2023 as a Pulmonary Disease Physician in SAINT CHARLES, Missouri, prescribing 35% generic.

4K
Part D claims, 2023
35%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

AHMAREEN KHAN, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

3,529 Top 10% higher than 90% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). Below this entry. 1,600–1,800: 19,072 prescribers (1%). Below this entry. 1,800–2,000: 16,451 prescribers (1%). Below this entry. 2,000–2,200: 213,991 prescribers (16%). This entry sits in this band. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

AHMAREEN KHAN, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about AHMAREEN KHAN, M.D.?

Quality data not reported

NPI registry status

Active

Issued 02/28/2006

NPI 1669449591

Primary specialty

Pulmonary Disease Physician

Mid-sized

9,271 US NPIs in this specialty

Medicare Part D claims

3,529 142% vs specialty avg

2023 prescription claims

Specialty avg: 1,457

Specialty distribution in Missouri

How Pulmonary Disease Physician compares to other specialties among Missouri providers

Missouri providers

Pulmonary Disease Physician share within Missouri

1. Pulmonary Disease Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pulmonary Disease Physician share within Missouri

Specialty board-certification context

Estimated specialty board-certified rate — Pulmonary Disease Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Pulmonary Disease Physician ABMS/AOA estimate

Est. board-certified rate (Pulmonary Disease Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Pulmonary Disease Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

AHMAREEN KHAN, M.D. appears in the CMS NPPES registry as a Pulmonary Disease Physician provider holding M.D. credentials at 400 1ST CAPITOL DR, SAINT CHARLES, MO, 63301, with a listed phone of (636) 669-0300. NPI 1669449591 was issued on 02/28/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KHAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 3,529 prescription claims written by this provider, covering 509 Medicare beneficiaries and totaling roughly $2.1 million in drug spend, split 65% brand-name and 35% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Pulmonary Disease Physician is a mid-sized specialty nationwide, with 9,271 enrolled providers across 53 states and an average of 1,457 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

400 1ST CAPITOL DR
SAINT CHARLES, MO 63301

Provider Details

NPI 1669449591
Specialty Pulmonary Disease Physician
Credentials M.D.
Gender Female
NPI Issued 02/28/2006

Hospital and facility affiliations

Facilities where AHMAREEN KHAN, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

AGING WELL HEALTH CARE, LLC
SAINT LOUIS, MO
SSM MEDICAL GROUP INC
LAKE ST LOUIS, MO

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Brand vs generic prescribing mix · Brand-heavy

AHMAREEN KHAN, M.D. — brand share 65.0%
Specialty average (est.)

65% brand-name claims vs 35% generic, on 3,529 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

3,529
Total Claims
$2.1M
Total Drug Cost
509
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
5,169
Total Day Supply
145,745
Brand vs Generic
65% brand / 35% generic
Brand Drug Cost
$2.0M
Antibiotic Claims
45

Patient Demographics

Average Patient Age
73.1 years
Avg HCC Risk Score
1.81
Gender Split
65% female / 35% male
Age Distribution
<65: 63, 65-74: 208, 75-84: 198, 85+: 40

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What AHMAREEN KHAN, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Trelegy Ellipta
Fluticasone/Umeclidin/Vilanter
1,102
Albuterol Sulfate Hfa
Albuterol Sulfate
479
Montelukast Sodium
433
Arnuity Ellipta
Fluticasone Furoate
166
Breo Ellipta
Fluticasone/Vilanterol
131
Fluticasone Propionate
95
Ventolin Hfa
Albuterol Sulfate
90
Flovent Hfa
Fluticasone Propionate
73
Symbicort
Budesonide/Formoterol Fumarate
70
Prednisone
63

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pulmonary Disease Physician Overview

How AHMAREEN KHAN, M.D. fits within the Pulmonary Disease Physician landscape nationally.

9,271
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,457
Avg Claims per Provider

AHMAREEN KHAN, M.D.'s 3,529 claims are above the specialty average of 1,457.

Nearby Pulmonary Disease Physician Providers in Missouri

Other clinicians with the same primary specialty enrolled in Missouri, drawn from the same CMS NPPES roster as KHAN.

Compare Pulmonary Disease Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is AHMAREEN KHAN, M.D.'s specialty?
AHMAREEN KHAN, M.D. specializes in Pulmonary Disease Physician and practices in SAINT CHARLES, Missouri. Credentials: M.D..
How much does AHMAREEN KHAN, M.D. prescribe under Medicare Part D?
In 2023, AHMAREEN KHAN, M.D. wrote 3,529 Medicare Part D claims totaling $2.1M in drug costs for 509 beneficiaries.
Where is AHMAREEN KHAN, M.D. located?
AHMAREEN KHAN, M.D. is located at 400 1ST CAPITOL DR, SAINT CHARLES, MO, 63301. Phone: (636) 669-0300.
What is AHMAREEN KHAN, M.D.'s NPI number?
AHMAREEN KHAN, M.D.'s National Provider Identifier (NPI) is 1669449591, issued on 02/28/2006.
Does AHMAREEN KHAN, M.D. prescribe more brand-name or generic drugs?
AHMAREEN KHAN, M.D.'s prescribing is 65% brand-name and 35% generic drugs by claim count, with $2.0M in brand drug costs.
How many Pulmonary Disease Physician providers are there in the US?
There are 9,271 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,457 Medicare Part D claims per year.
What drugs does AHMAREEN KHAN, M.D. prescribe most often?
Based on 2023 Medicare Part D data, AHMAREEN KHAN, M.D.'s most frequently prescribed drugs include Trelegy Ellipta, Albuterol Sulfate Hfa, Montelukast Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does AHMAREEN KHAN, M.D. accept Medicare?
AHMAREEN KHAN, M.D. appears in CMS Medicare data with 3,529 Part D claims and 509 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify AHMAREEN KHAN, M.D.'s credentials?
AHMAREEN KHAN, M.D.'s NPI is 1669449591 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology